Viking Therapeutics (VKTX) Tops Q2 EPS by 13c
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($1.10), $0.13 better than the analyst estimate of ($1.23).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($1.10), $0.13 better than the analyst estimate of ($1.23).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.